The TSP-1 antagonist is able to mediate TGF-b activation in fibrotic diseases, thereby targeting the TSP-1/TGF-b pathway potentially in a selective way in liver fibrosis treatment [19]. The gene discussed is THBS1; the disease is Hepatic fibrosis.